These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8669529)

  • 21. Atypical bronchial carcinoids. Review of 46 patients.
    Oliaro A; Filosso PL; Donati G; Ruffini E
    J Cardiovasc Surg (Torino); 2000 Feb; 41(1):131-5. PubMed ID: 10836239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoid tumors of the lung: do atypical features require aggressive management?
    Marty-Ané CH; Costes V; Pujol JL; Alauzen M; Baldet P; Mary H
    Ann Thorac Surg; 1995 Jan; 59(1):78-83. PubMed ID: 7818364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Prognostic Significance of TNM Staging Guidelines in Lung Carcinoid Tumors.
    Yoon JY; Sigel K; Martin J; Jordan R; Beasley MB; Smith C; Kaufman A; Wisnivesky J; Kim MK
    J Thorac Oncol; 2019 Feb; 14(2):184-192. PubMed ID: 30414942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid.
    Velinovic M; Jankovic R; Jovanovic D; Skodric Trifunovic V; Gavrilovic D; Stojsic J; Cavic M
    J BUON; 2019; 24(1):256-266. PubMed ID: 30941978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival.
    Skov BG; Krasnik M; Lantuejoul S; Skov T; Brambilla E
    J Thorac Oncol; 2008 Dec; 3(12):1410-5. PubMed ID: 19057265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchial carcinoid tumors: long-term outcome after surgery.
    Fiala P; Petrásková K; Cernohorský S; Kinkor Z; Krepela E; Zatloukal P
    Neoplasma; 2003; 50(1):60-5. PubMed ID: 12687280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome and prognostic factors in bronchial carcinoids: a single-center experience.
    Filosso PL; Oliaro A; Ruffini E; Bora G; Lyberis P; Asioli S; Delsedime L; Sandri A; Guerrera F
    J Thorac Oncol; 2013 Oct; 8(10):1282-8. PubMed ID: 24457239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung carcinoids. Tumor angiogenesis in relation to clinicopathologic characteristics.
    Slodkowska J; Sikora J; Androsiuk W; Rudziński P; Radomyski A
    Anal Quant Cytol Histol; 1999 Jun; 21(3):267-72. PubMed ID: 10560502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids.
    Pelosi G; Pasini F; Fraggetta F; Pastorino U; Iannucci A; Maisonneuve P; Arrigoni G; De Manzoni G; Bresaola E; Viale G
    Lung Cancer; 2003 Nov; 42(2):203-13. PubMed ID: 14568688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors.
    Lee PC; Osakwe NC; Narula N; Port JL; Paul S; Stiles BM; Andrews WG; Nasar A; Altorki NK
    Thorac Cardiovasc Surg; 2016 Mar; 64(2):159-65. PubMed ID: 25756243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids.
    Ferolla P; Daddi N; Urbani M; Semeraro A; Ribacchi R; Giovenali P; Ascani S; De Angelis V; Crinò L; Puma F; Daddi G;
    J Thorac Oncol; 2009 Mar; 4(3):383-7. PubMed ID: 19247084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Typical and atypical bronchial carcinoids.
    Torre M; Barberis M; Barbieri B; Bonacina E; Belloni P
    Respir Med; 1989 Jul; 83(4):305-8. PubMed ID: 2608951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA content and prognosis in renal cell carcinoma. A comparison between primary tumors and metastases.
    Ljungberg B; Stenling R; Roos G
    Cancer; 1986 Jun; 57(12):2346-50. PubMed ID: 3697934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung.
    Yang Z; Wang Z; Duan Y; Xu S
    Thorac Cancer; 2016 Nov; 7(6):633-638. PubMed ID: 27755793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interobserver variability for the WHO classification of pulmonary carcinoids.
    Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
    Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of deoxyribonucleic acid content in metastatic renal cell carcinoma.
    Ljungberg B; Stenling R; Roos G
    J Urol; 1986 Oct; 136(4):801-4. PubMed ID: 3761435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
    Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
    J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome after resection for bronchial carcinoid tumors.
    Ferguson MK; Landreneau RJ; Hazelrigg SR; Altorki NK; Naunheim KS; Zwischenberger JB; Kent M; Yim AP
    Eur J Cardiothorac Surg; 2000 Aug; 18(2):156-61. PubMed ID: 10925223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchial adenoma: a review of 51 patients.
    Attar S; Miller JE; Hankins J; Thompson BW; Suter CM; Kleger PJ; McLaughlin JS
    Ann Thorac Surg; 1985 Aug; 40(2):126-32. PubMed ID: 2992400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.